Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Nov 2, 2009
Financial News
Xanodyne Pharmaceuticals completes venture financing
...Management; Skandia; Silver Point Capital; MPM Capital; AIG; Perseus-Soros Biopharmaceutical Fund; Blue Chip; HealthCare Ventures;
Union Springs
WIR...
Read More
BioCentury
|
Oct 30, 2009
Financial News
Xanodyne raises $50 million
...joined existing investors MPM Capital; AIG Investments; Perseus-Soros Biopharmaceutical Fund; Blue Chip; HealthCare Ventures; and
Union Springs
...
Read More
BioCentury
|
Jun 8, 2009
Financial News
Xanodyne Pharmaceuticals completes venture financing
...million Investors: MPM Capital; AIG; Aisling Capital; Blue Chip; Essex Woodlands Health Ventures; HealthCare Ventures;
Union Springs
WIR...
Read More
BioCentury
|
Jun 5, 2009
Financial News
Xanodyne raises $38M, names Valentino CEO
...by MPM Capital. AIG Investments; Aisling Capital; Blue Chip Venture; Essex Woodlands; HealthCare Ventures; and
Union Springs
...
Read More
BioCentury
|
Feb 1, 2005
Financial News
PediaMed raises $15 million
...in a series C round led by Essex Woodlands Health Ventures; Blue Chip Capital; and
Union Springs
...
Read More
Items per page:
10
1 - 5 of 5
BioCentury
|
Nov 2, 2009
Financial News
Xanodyne Pharmaceuticals completes venture financing
...Management; Skandia; Silver Point Capital; MPM Capital; AIG; Perseus-Soros Biopharmaceutical Fund; Blue Chip; HealthCare Ventures;
Union Springs
WIR...
Read More
BioCentury
|
Oct 30, 2009
Financial News
Xanodyne raises $50 million
...joined existing investors MPM Capital; AIG Investments; Perseus-Soros Biopharmaceutical Fund; Blue Chip; HealthCare Ventures; and
Union Springs
...
Read More
BioCentury
|
Jun 8, 2009
Financial News
Xanodyne Pharmaceuticals completes venture financing
...million Investors: MPM Capital; AIG; Aisling Capital; Blue Chip; Essex Woodlands Health Ventures; HealthCare Ventures;
Union Springs
WIR...
Read More
BioCentury
|
Jun 5, 2009
Financial News
Xanodyne raises $38M, names Valentino CEO
...by MPM Capital. AIG Investments; Aisling Capital; Blue Chip Venture; Essex Woodlands; HealthCare Ventures; and
Union Springs
...
Read More
BioCentury
|
Feb 1, 2005
Financial News
PediaMed raises $15 million
...in a series C round led by Essex Woodlands Health Ventures; Blue Chip Capital; and
Union Springs
...
Read More
Items per page:
10
1 - 5 of 5
Previous page
Next page